МАСБП: загадки жирной печени, сердца и новые лекарства от ресметирома до генетики
The Lancet Diabetes and Endocrinology Volume 13, Issue 2p134-148 February 2025 Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment https://www.thelancet.com/journals/landia/article/PIIS2213-8587(24)00318-8/fulltext?s=03
The Lancet Diabetes and Endocrinology Volume 13, Issue 2p134-148 February 2025 Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment https://www.thelancet.com/journals/landia/article/PIIS2213-8587(24)00318-8/fulltext?s=03
